PROTEOMICS & METABOLOMICS SHARED RESOURCE (P&MSR) The Proteomics and Metabolomics Shared Resource (P&MSR) consists of the Fred Hutch (FH)-based Proteomics Facility and the University of Washington South Lake Union (UW-SLU) Metabolomics Facility. The P&MSR Proteomics Facility was formed in 2002 and has been under the direction of Dr. Phil Gafken since its inception. The P&MSR Metabolomics Facility was formed in 2013 and has been under the direction of Dr. Daniel Raftery. The mission of the P&MSR is (1) to provide high-quality, cost-effective, and reliable service in a timely manner for proteomics and metabolomics experiments; (2) to develop and implement new omics experiments, assays, and tools to uncover the molecular details influencing cancer biology; and (3) to support the development of translatable and clinical tests. The P&MSR operates and maintains chromatography, mass spectrometry, and nuclear magnetic resonance instruments and offers services such as experimental design and consultation, sample preparation and chromatography, protein or metabolite identification and quantification, protein modification characterization, targeted protein or metabolite quantification, metabolic flux analysis, and data analysis and informatics support. New technologies and services are continually being evaluated based on feedback from Consortium members. Over the next granting period, areas of interest that will be investigated include the analysis of major histocompatibility complex peptides to support cancer immunology and immunotherapy research. For metabolomics we will add to our over 20 current assays by expanding our capabilities to measure metabolic flux, provide the capability to investigate real-time metabolism studies using stable isotope tracers, and develop higher throughput global profiling assays to support research in cancer biology. With well-established operation policies, Consortium users have cost-effective, reliable, and immediate access to the P&MSR. The research supported by the P&MSR demonstrates that it is an important part of the critical Shared Resources infrastructure needed to support the Fred Hutch/University of Washington Cancer Consortium.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA015704-46
Application #
10125956
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-01-01
Project End
2024-12-31
Budget Start
2021-01-01
Budget End
2021-12-31
Support Year
46
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Georges, George E; Doney, Kris; Storb, Rainer (2018) Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment. Blood Adv 2:2020-2028
Duggan, Catherine; Tapsoba, Jean de Dieu; Stanczyk, Frank et al. (2018) Long-term weight loss maintenance, sex steroid hormones, and sex hormone-binding globulin. Menopause :
Yu, Ming; Maden, Sean K; Stachler, Matthew et al. (2018) Subtypes of Barrett's oesophagus and oesophageal adenocarcinoma based on genome-wide methylation analysis. Gut :
Lam, Hung-Ming; Corey, Eva (2018) Supraphysiological Testosterone Therapy as Treatment for Castration-Resistant Prostate Cancer. Front Oncol 8:167
Fowler, Kyle R; Hyppa, Randy W; Cromie, Gareth A et al. (2018) Physical basis for long-distance communication along meiotic chromosomes. Proc Natl Acad Sci U S A 115:E9333-E9342
Ogimi, Chikara; Xie, Hu; Leisenring, Wendy M et al. (2018) Initial High Viral Load Is Associated with Prolonged Shedding of Human Rhinovirus in Allogeneic Hematopoietic Cell Transplant Recipients. Biol Blood Marrow Transplant 24:2160-2163
Jeong, Kyoung Sook; Zhou, Jin; Griffin, Stephanie C et al. (2018) MicroRNA Changes in Firefighters. J Occup Environ Med 60:469-474
Appelbaum, Jacob; Wells, David; Hiatt, Joseph B et al. (2018) Fatal enteric plexus neuropathy after one dose of ipilimumab plus nivolumab: a case report. J Immunother Cancer 6:82
Blair, Kris M; Mears, Kevin S; Taylor, Jennifer A et al. (2018) The Helicobacter pylori cell shape promoting protein Csd5 interacts with the cell wall, MurF, and the bacterial cytoskeleton. Mol Microbiol 110:114-127
Talarico, Sarah; Korson, Andrew S; Leverich, Christina K et al. (2018) High prevalence of Helicobacter pylori clarithromycin resistance mutations among Seattle patients measured by droplet digital PCR. Helicobacter 23:e12472

Showing the most recent 10 out of 1267 publications